Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Curti

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|July 5, 2019
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distanceMarcus A Couey, R Bryan Bell, Ashish A Patel, et al.
The Cancer Journal From Scientific American|March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemiaB Arun, B D Curti, D L Longo, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|December 24, 2002
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutationD Curti, F Rognoni, D Alimonti, et al.
Journal for Immunotherapy of Cancer|October 27, 2015
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanomaZipei Feng, Sachin Puri, Tarsem Moudgil, et al.
Science Translational Medicine|June 8, 2012
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responsesSteven K Seung, Brendan D Curti, Marka Crittenden, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humansJ E Janik, B D Curti, R V Considine, et al.
Biochemical Pharmacology|September 7, 2001
Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubesO Cazzalini, M C Lazzè, L Iamele, et al.
Cancer Investigation|July 29, 1998
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanomaB L Gause, W H Sharfman, J E Janik, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Blood|April 1, 1997
Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunityM L Saxton, D L Longo, H E Wetzel, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|July 5, 2019
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distanceMarcus A Couey, R Bryan Bell, Ashish A Patel, et al.
The Cancer Journal From Scientific American|March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemiaB Arun, B D Curti, D L Longo, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|December 24, 2002
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutationD Curti, F Rognoni, D Alimonti, et al.
Journal for Immunotherapy of Cancer|October 27, 2015
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanomaZipei Feng, Sachin Puri, Tarsem Moudgil, et al.
Science Translational Medicine|June 8, 2012
Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responsesSteven K Seung, Brendan D Curti, Marka Crittenden, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humansJ E Janik, B D Curti, R V Considine, et al.
Biochemical Pharmacology|September 7, 2001
Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubesO Cazzalini, M C Lazzè, L Iamele, et al.
Cancer Investigation|July 29, 1998
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanomaB L Gause, W H Sharfman, J E Janik, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Blood|April 1, 1997
Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunityM L Saxton, D L Longo, H E Wetzel, et al.
Pageof 13